Yellow Bird Competitors

Butterfly’s mission is to democratize healthcare by making medical imaging accessible to everyone, everywhere. As pioneers of semiconductor chip-based ultrasound, we are creating a new standard of care through transformative digital technologies – from probe to platform. Our integrated hardware, software, and AI-powered tools, along with education and partnership opportunities through our software development kit (SDK) offering, empower healthcare providers and enterprises to deliver faster answers and enable better care – wherever care is needed. iQ3: Best Medical Technology Winner @ 2024 Prix Galien USA Awards Have a story to share with us? We’d love to hear from you. Email connect@butterflynetinc.com

bluebird bio has rebranded as Genetix Biotherapeutics, returning to our foundational roots and renewing our commitment to delivering transformative genetic therapies for patients living with sickle cell disease, β-thalassemia, and cerebral adrenoleukodystrophy. Follow our new page at the link below!

RedBird Capital Partners is a private investment firm that builds high-growth companies with strategic capital solutions to founders and entrepreneurs. The firm currently manages approximately $14 billion in assets on behalf of a global group of blue chip institutional and family office investors. Founded in 2014 by Gerry Cardinale, RedBird integrates sophisticated private equity investing with a hands-on business building mandate that focuses on three core industry verticals – Sports, Media & Entertainment, and Financial Services. Throughout his 30-year investment career, Cardinale has partnered with founders and entrepreneurs to build some of the most iconic growth companies in their respective industries. For more information, please go to www.redbirdcap.com.